Assembly Biosciences Inc (NASDAQ:ASMB)

46.64
Delayed Data
As of Apr 18
 -0.94 / -1.98%
Today’s Change
18.60
Today|||52-Week Range
67.36
+3.07%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$1.2B

Company Description

Assembly Biosciences, Inc. is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. It focuses in two innovative platform programs: oral therapeutics for the treatment of hepatitis B virus, and the oral synthetic live biotherapeutics designed to restore health to a dysbiotic microbiome. The company was founded by Uri Lopatin on October 7, 2005 and is headquartered in Carmel, IN.

Contact Information

Assembly Biosciences, Inc.
11711 North Meridiyan Street
Carmel Indiana 46032
P:(855) 971-4467
Investor Relations:
(415) 521-3828

Employees

Shareholders

Other institutional55.70%
Mutual fund holders21.86%
Individual stakeholders14.96%

Top Executives

Derek A. SmallPresident, Chief Executive Officer & Director
Graham K. CooperChief Operating & Financial Officer
Uri A. LopatinChief Medical Officer, VP-Research & Development
Jackie PapkoffSenior VP & Chief Scientific Officer-Microbiome
Richard J. ColonnoEVP & Chief Scientific Officer-Virology Operations